Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Hematologic Oncology Update
00:00
Comparing Efficacy and Placement of Immunotherapies in Non-Hodgkin Lymphoma
Discussion on the challenges and outcomes of different treatments for non-Hodgkin lymphoma, comparing the efficacy of Axie Cell and T-S-L and the potential for immunotherapies to change the concept of the disease.
Transcript
Play full episode
